Healthcare Equipment and Supplies
Company Overview of Ekso Bionics Holdings, Inc.
Ekso Bionics Holdings, Inc. designs, develops, and sells wearable robots or exoskeletons for use in the medical, military, industrial, and consumer markets in North America, Western Europe, the Middle East, and South Africa. The company operates through Engineering Services and Medical segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, stroke, and other lower-extremity paralysis or weakness. The company’s Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exoskel...
1414 Harbour Way South
Richmond, CA 94804
Founded in 2005
Key Executives for Ekso Bionics Holdings, Inc.
Co-Founder, Chief Executive Officer and Director
Total Annual Compensation: $401.1K
President and Chief Commercial Officer
Total Annual Compensation: $201.7K
Co-Founder and President of Ekso Labs Division
Total Annual Compensation: $323.0K
Chief Financial Officer
Total Annual Compensation: $323.0K
Compensation as of Fiscal Year 2014.
Ekso Bionics Holdings, Inc. Key Developments
Ekso Bionics Holdings, Inc. to Reveal New SmartAssist Software At DMGP in Kassel, Germany
Jun 25 15
Ekso Bionics Holdings, Inc. announced that the latest Ekso Bionics robotic gait therapy software upgrade, first available in Europe, will be revealed at the 28th Annual Meeting of the German Speaking Medical Society for Paraplegia (DMGP) in Kassel, Germany. Ekso GT with SmartAssist features include: the next generation of adaptive assistance software, enabling a greater number of interactive steps; PreGait, a suite of early mobilization activities for pre-ambulatory patients preparing for gait therapy; and FreeGait, an advanced mode for patients progressing to community ambulation. This new Ekso GT package will also support integration of Functional Electric Stimulation (FES) from Hasomed for research use, providing the opportunity for facilities operating under research protocols to partner with Ekso to advance research on complimentary therapies. Ekso GT with new SmartAssist software supports a broader spectrum of patients who are more actively engaged in their rehabilitation. The new SmartAssist programming provides patients with an unparalleled ability to vary the step path based on their own effort. High step variability has been associated with enhanced locomotor rehabilitation. The company's commercial plan anticipates an initial launch of the SmartAssist robotic gait therapy software package for Ekso GT in Europe by the end of 2015. The SmartAssist software is not yet available in the United States.
Ekso Bionics Seeks Acquisitions
Jun 23 15
Ekso Bionics Holdings, Inc. (OTCBB:EKSO) has filed a Shelf Registration in the amount of $75.00 million. Unless otherwise indicated in the applicable prospectus supplement, Ekso intends to use any net proceeds from the sale of securities under this prospectus in the development and commercialization of able-bodied exoskeletons for industrial use, and for other general corporate purposes, including, but not limited to, working capital, intellectual property protection and enforcement, capital expenditures, investments, acquisitions and collaborations.
Ekso Bionics Holdings, Inc. Secures Third Contract with the U.S. Special Operations Command
May 20 15
Ekso Bionics Holdings, Inc. announced that their Ekso Labs division secured a third contract with the United States Special Operations Command (SOCOM) to work on the next phase of the Tactical Assault Light Operator Suit (TALOS) project. Following the completion of a previous SOCOM project, the latest will focus on the development of an upper extremity part for TALOS Mk III. Additionally the US Patent Office has now granted Ekso Bionics three new patents resulting from their work on DARPA and other government agency projects. SOCOM announced last year that it was working to create a wearable uniform, which provides superhuman capabilities with superior mobility and protection, for their Special Operations Forces. U.S. Special Operations Command is moving forward in the development of its exoskeleton that would give Special Forces troops head-to-toe ballistic protection while allowing for fluid movements. Ekso Bionics designs, develops, and commercializes exoskeletons, or wearable robots, which have a variety of applications in the medical, military, industrial, and consumer markets. Exoskeletons are ready-to-wear, battery-powered robots that are strapped over the user's clothing, enabling individuals to achieve mobility, strength, and endurance not otherwise possible.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|